Neurology clinical trials

Explore recruiting neurology clinical trials.

Recruiting neurology studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neurology trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A RANDOMIZED DOUBLE BLIND, PLACEBO-CONTROLLED NATIONAL MULTICENTER PHASE 3 TRIAL TO EVALUATE THE EFFICACY OF AZATHIOPRINE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY ASSOCIATED DISEASE (MOG-AD) AFTER A FIRST ATTACK : MOGWAI

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Impact of epilepsy on the brainstem adenosine pathway and its relation with arousal and respiratory reactivity BRAVE

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A PET-MRI study of serotoninergic brainstem pathway in patients with Dravet Syndrome - DRAPETONINE

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Diving into the noradrenergic system : Role of the alpha2C-adrenergic receptors NA2C-TEP-IRM

France

Therapeutic exploratory (Phase II) EU CTIS Study details

P3-IMU-838-RMS-02 - A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-2)

Romania, Germany, Estonia, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

P3-IMU-838-RMS-01 - A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-1)

Germany, Lithuania, Bulgaria, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neurology trials by city

Neurology in Toronto Neurology in Vancouver Neurology in Montreal Neurology in Calgary Neurology in Edmonton Neurology in Ottawa Neurology in Winnipeg Neurology in Quebec City Neurology in Hamilton Neurology in Kitchener Neurology in London Neurology in Halifax Neurology in New York Neurology in Los Angeles Neurology in Chicago Neurology in Houston

Neurology clinical trials

Recruiting neurology studies right now

Clinical Evaluation of Sensory Neuronopathies: the Neuronoscore Study

Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias

[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder

Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study

High Dose Steroids in Children With Stroke

The Effectiveness of Conservative Treatment in Patients With Complex Regional Pain Syndrome.

Early Doppler-Assisted Mobilization in Adults After Acute Ischemic Stroke

Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study

BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe

Evaluation of the Performance of the Doraldo-Castelletti Scale in Supporting the Neurologist's Decision to Refer Migraine Patients to Physiotherapy

Also recruiting in Europe

A RANDOMIZED DOUBLE BLIND, PLACEBO-CONTROLLED NATIONAL MULTICENTER PHASE 3 TRIAL TO EVALUATE THE EFFICACY OF AZATHIOPRINE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY ASSOCIATED DISEASE (MOG-AD) AFTER A FIRST ATTACK : MOGWAI

Impact of epilepsy on the brainstem adenosine pathway and its relation with arousal and respiratory reactivity BRAVE

A PET-MRI study of serotoninergic brainstem pathway in patients with Dravet Syndrome - DRAPETONINE

Diving into the noradrenergic system : Role of the alpha2C-adrenergic receptors NA2C-TEP-IRM

P3-IMU-838-RMS-02 - A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-2)

P3-IMU-838-RMS-01 - A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-1)

Neurology trials by city

Other conditions